Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Colistin Resistance Development Following Colistin-Meropenem Combination Therapy vs. Colistin Monotherapy in Patients with Infections Caused by Carbapenem-Resistant Organisms.

Dickstein Y, Lellouche J, Schwartz D, Nutman A, Rakovitsky N, Dishon Benattar Y, Altunin S, Bernardo M, Iossa D, Durante-Mangoni E, Antoniadou A, Skiada A, Deliolanis I, Daikos GL, Daitch V, Yahav D, Leibovici L, Rognås V, Friberg LE, Mouton JW, Paul M, Carmeli Y; AIDA study group.

Clin Infect Dis. 2019 Nov 23. pii: ciz1146. doi: 10.1093/cid/ciz1146. [Epub ahead of print]

PMID:
31758195
2.

Risk of congenital cytomegalovirus infection in children born to women with IgG avidity in the grey zone during first trimester of pregnancy.

Kekkou K, Kavatha D, Karalexi M, Galani L, Dimopoulou D, Papaevangelou V, Antoniadou A.

J Matern Fetal Neonatal Med. 2019 Aug 11:1-5. doi: 10.1080/14767058.2019.1651277. [Epub ahead of print]

PMID:
31401915
3.

Dissemination of International Clone II Acinetobacter baumannii Strains Coproducing OXA-23 Carbapenemase and 16S rRNA Methylase ArmA in Athens, Greece.

Nafplioti K, Galani I, Angelidis E, Adamou P, Moraitou E, Giannopoulou P, Chra P, Damala M, Vogiatzakis E, Trikka-Graphakos E, Baka V, Prifti E, Antoniadou A, Souli M.

Microb Drug Resist. 2019 Aug 8. doi: 10.1089/mdr.2019.0075. [Epub ahead of print]

PMID:
31393211
4.

Low-Dose Cotrimoxazole Administered in Hematopoietic Stem Cell Transplant Recipients as Prophylaxis for Pneumocystis jirovecii Pneumonia Is Effective in Prevention of Infection due to Nocardia.

Gkirkas K, Stamouli M, Thomopoulos T, Kontos F, Kavatha D, Siafakas N, Karagiannidou A, Pournaras S, Antoniadou A, Tsirigotis P.

Biol Blood Marrow Transplant. 2019 Sep;25(9):e298-e299. doi: 10.1016/j.bbmt.2019.07.018. Epub 2019 Jul 18. No abstract available.

PMID:
31326612
5.

Long-term evolution of CD4+ cell count in patients under combined antiretroviral therapy.

Pantazis N, Papastamopoulos V, Paparizos V, Metallidis S, Adamis G, Antoniadou A, Psichogiou M, Chini M, Sambatakou H, Sipsas NV, Gogos C, Chrysos G, Panagopoulos P, Katsarou O, Gikas A, Touloumi G; AMACS.

AIDS. 2019 Aug 1;33(10):1645-1655. doi: 10.1097/QAD.0000000000002248.

PMID:
31305332
6.

Correction to: In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.

Galani I, Souli M, Nafplioti K, Adamou P, Karaiskos I, Giamarellou H, Antoniadou A; Study Collaborators.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1151-1152. doi: 10.1007/s10096-019-03553-8.

PMID:
31037478
7.

Identifying, linking, and treating people who inject drugs and were recently infected with HIV in the context of a network-based intervention.

Psichogiou M, Giallouros G, Pantavou K, Pavlitina E, Papadopoulou M, Williams LD, Hadjikou A, Kakalou E, Skoutelis A, Protopapas K, Antoniadou A, Boulmetis G, Paraskevis D, Hatzakis A, Friedman SR, Nikolopoulos GK.

AIDS Care. 2019 Nov;31(11):1376-1383. doi: 10.1080/09540121.2019.1601671. Epub 2019 Apr 2.

PMID:
30939897
8.

Genomic characterization of a KPC-23-producing Klebsiella pneumoniae ST258 clinical isolate resistant to ceftazidime-avibactam.

Galani I, Antoniadou A, Karaiskos I, Kontopoulou K, Giamarellou H, Souli M.

Clin Microbiol Infect. 2019 Jun;25(6):763.e5-763.e8. doi: 10.1016/j.cmi.2019.03.011. Epub 2019 Mar 28.

PMID:
30928562
9.

In vitro activity of imipenem-relebactam against non-MBL carbapenemase-producing Klebsiella pneumoniae isolated in Greek hospitals in 2015-2016.

Galani I, Souli M, Nafplioti K, Adamou P, Karaiskos I, Giamarellou H, Antoniadou A; Study Collaborators.

Eur J Clin Microbiol Infect Dis. 2019 Jun;38(6):1143-1150. doi: 10.1007/s10096-019-03517-y. Epub 2019 Mar 1. Erratum in: Eur J Clin Microbiol Infect Dis. 2019 Apr 29;:.

PMID:
30825054
10.

Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.

Dickstein Y, Lellouche J, Ben Dalak Amar M, Schwartz D, Nutman A, Daitch V, Yahav D, Leibovici L, Skiada A, Antoniadou A, Daikos GL, Andini R, Zampino R, Durante-Mangoni E, Mouton JW, Friberg LE, Dishon Benattar Y, Bitterman R, Neuberger A, Carmeli Y, Paul M; AIDA Study Group .

Clin Infect Dis. 2019 Aug 16;69(5):769-776. doi: 10.1093/cid/ciy988.

PMID:
30462182
11.

Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility.

Lellouche J, Schwartz D, Elmalech N, Ben Dalak MA, Temkin E, Paul M, Geffen Y, Yahav D, Eliakim-Raz N, Durante-Mangoni E, Iossa D, Bernardo M, Daikos GL, Skiada A, Pantazatou A, Antoniadou A, Mouton JW, Carmeli Y; AIDA study group.

Clin Microbiol Infect. 2019 Jun;25(6):711-716. doi: 10.1016/j.cmi.2018.09.014. Epub 2018 Oct 4.

PMID:
30291971
12.

The HIV patient profile in 2013 and 2003: Results from the Greek AMACS cohort.

Pantazis N, Chini M, Antoniadou A, Sambatakou H, Skoutelis A, Gargalianos P, Kourkounti S, Gogos C, Chrysos G, Psichogiou M, Sipsas NV, Katsarou O, Panagopoulos P, Metallidis S, Touloumi G; AMACS.

PLoS One. 2018 Sep 12;13(9):e0203601. doi: 10.1371/journal.pone.0203601. eCollection 2018.

13.

Management of Invasive Fungal Infections in Adult Patients with Hematological Malignancies in Greece during the Financial Crisis: Challenges and Recommendations.

Sipsas NV, Pagoni MN, Kofteridis DP, Meletiadis J, Vrioni G, Papaioannou M, Antoniadou A, Petrikkos G, Samonis G.

J Fungi (Basel). 2018 Aug 9;4(3). pii: E94. doi: 10.3390/jof4030094.

14.

The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.

Zak-Doron Y, Dishon Benattar Y, Pfeffer I, Daikos GL, Skiada A, Antoniadou A, Durante-Mangoni E, Andini R, Cavezza G, Leibovici L, Yahav D, Eliakim-Raz N, Carmeli Y, Nutman A, Paul M; AIDA Study Group.

Clin Infect Dis. 2018 Nov 28;67(12):1815-1823. doi: 10.1093/cid/ciy371.

PMID:
29718143
15.

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial.

Paul M, Daikos GL, Durante-Mangoni E, Yahav D, Carmeli Y, Benattar YD, Skiada A, Andini R, Eliakim-Raz N, Nutman A, Zusman O, Antoniadou A, Pafundi PC, Adler A, Dickstein Y, Pavleas I, Zampino R, Daitch V, Bitterman R, Zayyad H, Koppel F, Levi I, Babich T, Friberg LE, Mouton JW, Theuretzbacher U, Leibovici L.

Lancet Infect Dis. 2018 Apr;18(4):391-400. doi: 10.1016/S1473-3099(18)30099-9. Epub 2018 Feb 16.

PMID:
29456043
16.

GnRH-dependent precocious puberty manifested at the age of 14 months in a girl with 47,XXX karyotype.

Skordis N, Ferrari E, Antoniadou A, Phylactou LA, Fanis P, Neocleous V.

Hormones (Athens). 2017 Jul;16(3):318-321. doi: 10.14310/horm.2002.1740.

17.

Combination therapy for extensively-drug resistant gram-negative bacteria.

Karaiskos I, Antoniadou A, Giamarellou H.

Expert Rev Anti Infect Ther. 2017 Dec;15(12):1123-1140. doi: 10.1080/14787210.2017.1410434. Epub 2017 Dec 1. Review.

PMID:
29172792
18.

Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public Health.

Paraskevis D, Kostaki E, Gargalianos P, Xylomenos G, Lazanas M, Chini M, Skoutelis A, Papastamopoulos V, Paraskeva D, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos GL, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Sipsas NV, Lada M, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

Genes (Basel). 2017 Nov 13;8(11). pii: E322. doi: 10.3390/genes8110322.

19.

Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions.

Paraskevis D, Kostaki E, Magiorkinis G, Gargalianos P, Xylomenos G, Magiorkinis E, Lazanas M, Chini M, Nikolopoulos G, Skoutelis A, Papastamopoulos V, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos GL, Oikonomopoulou M, Zavitsanou A, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Sipsas NV, Lada M, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

Infect Genet Evol. 2017 Oct;54:183-191. doi: 10.1016/j.meegid.2017.07.003. Epub 2017 Jul 5.

PMID:
28688977
20.

Reliability, Validity and Psychometric Properties of the Greek Translation of the Posttraumatic Stress Disorder Scale.

Kontoangelos K, Tsiori S, Poulakou G, Protopapas K, Katsarolis I, Sakka V, Kavatha D, Papadopoulos A, Antoniadou A, Papageorgiou CC.

Ment Illn. 2017 Apr 7;9(1):6832. doi: 10.4081/mi.2017.6832. eCollection 2017 Mar 22.

21.

Reduction of Environmental Contamination With Multidrug-Resistant Bacteria by Copper-Alloy Coating of Surfaces in a Highly Endemic Setting.

Souli M, Antoniadou A, Katsarolis I, Mavrou I, Paramythiotou E, Papadomichelakis E, Drogari-Apiranthitou M, Panagea T, Giamarellou H, Petrikkos G, Armaganidis A.

Infect Control Hosp Epidemiol. 2017 Jul;38(7):765-771. doi: 10.1017/ice.2017.52. Epub 2017 May 5.

PMID:
28473010
22.

RELIABILITY, VALIDITY, AND PSYCHOMETRIC PROPERTIES OF THE GREEK TRANSLATION OF THE CAMBRIDGE DEPERSONALIZATION SCALE (CDS).

Kontoangelos K, Tsiori S, Poulakou G, Protopapas K, Katsarolis I, Sakka V, Kavatha D, Papadopoulos A, Antoniadou A, Papageorgiou CC.

Mater Sociomed. 2016 Oct;28(5):387-391. doi: 10.5455/msm.2016.28.387-391. Epub 2016 Oct 17.

23.

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol.

Dickstein Y, Leibovici L, Yahav D, Eliakim-Raz N, Daikos GL, Skiada A, Antoniadou A, Carmeli Y, Nutman A, Levi I, Adler A, Durante-Mangoni E, Andini R, Cavezza G, Mouton JW, Wijma RA, Theuretzbacher U, Friberg LE, Kristoffersson AN, Zusman O, Koppel F, Dishon Benattar Y, Altunin S, Paul M; AIDA consortium.

BMJ Open. 2016 Apr 20;6(4):e009956. doi: 10.1136/bmjopen-2015-009956.

24.

Carbapenemase-producing Klebsiella pneumoniae bloodstream infections in neutropenic patients with haematological malignancies or aplastic anaemia: Analysis of 50 cases.

Tofas P, Skiada A, Angelopoulou M, Sipsas N, Pavlopoulou I, Tsaousi S, Pagoni M, Kotsopoulou M, Perlorentzou S, Antoniadou A, Pirounaki M, Skoutelis A, Daikos GL.

Int J Antimicrob Agents. 2016 Apr;47(4):335-9. doi: 10.1016/j.ijantimicag.2016.01.011. Epub 2016 Feb 26.

PMID:
27005460
25.

Eosinophilia Associated With Olanzapine.

Tournikioti K, Douzenis A, Antoniadou A, Papazahos K, Moschos C, Papageorgiou C, Rizos EN.

J Clin Psychopharmacol. 2016 Apr;36(2):180-1. doi: 10.1097/JCP.0000000000000481. No abstract available.

PMID:
26872116
26.

Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ; SPREAD Program, Puchhammer-Stockl E, Sarcletti M, Schmied B, Geit M, Balluch G, Vandamme AM, Vercauteren J, Derdelinckx I, Sasse A, Bogaert M, Ceunen H, De Roo A, De Wit S, Echahidi F, Fransen K, Goffard JC, Goubau P, Goudeseune E, Yombi JC, Lacor P, Liesnard C, Moutschen M, Pierard D, Rens R, Schrooten Y, Vaira D, Vandekerckhove LPR, Van den Heuvel A, Van Der Gucht B, Van Ranst M, Van Wijngaerden E, Vandercam B, Vekemans M, Verhofstede C, Clumeck N, Van Laethem K, Beshkov D, Alexiev I, Lepej SZ, Begovac J, Kostrikis L, Demetriades I, Kousiappa I, Demetriou V, Hezka J, Linka M, Maly M, Machala L, Nielsen C, Jørgensen LB, Gerstoft J, Mathiesen L, Pedersen C, Nielsen H, Laursen A, Kvinesdal B, Liitsola K, Ristola M, Suni J, Sutinen J, Descamps D, Assoumou L, Castor G, Grude M, Flandre P, Storto A, Hamouda O, Kücherer C, Berg T, Braun P, Poggensee G, Däumer M, Eberle J, Heiken H, Kaiser R, Knechten H, Korn K, Müller H, Neifer S, Schmidt B, Walter H, Gunsenheimer-Bartmeyer B, Harrer T, Paraskevis D, Hatzakis A, Zavitsanou A, Vassilakis A, Lazanas M, Chini M, Lioni A, Sakka V, Kourkounti S, Paparizos V, Antoniadou A, Papadopoulos A, Poulakou G, Katsarolis I, Protopapas K, Chryssos G, Drimis S, Gargalianos P, Xylomenos G, Lourida G, Psichogiou M, Daikos GL, Sipsas NV, Kontos A, Gamaletsou MN, Koratzanis G, Sambatakou H, Mariolis H, Skoutelis A, Papastamopoulos V, Georgiou O, Panagopoulos P, Maltezos E, Coughlan S, De Gascun C, Byrne C, Duffy M, Bergin C, Reidy D, Farrell G, Lambert J, O'Connor E, Rochford A, Low J, Coakely P, O'Dea S, Hall W, Mor O, Levi I, Chemtob D, Grossman Z, Zazzi M, de Luca A, Balotta C, Riva C, Mussini C, Caramma I, Capetti A, Colombo MC, Rossi C, Prati F, Tramuto F, Vitale F, Ciccozzi M, Angarano G, Rezza G, Kolupajeva T, Vasins O, Griskevicius A, Lipnickiene V, Schmit JC, Struck D, Sauvageot N, Hemmer R, Arendt V, Michaux C, Staub T, Sequin-Devaux C, Wensing AMJ, Boucher CAB, van de Vijver DAMC, van Kessel A, van Bentum PHM, Brinkman K, Connell BJ, van der Ende ME, Hoepelman IM, van Kasteren M, Kuipers M, Langebeek N, Richter C, Santegoets RMWJ, Schrijnders-Gudde L, Schuurman R, van de Ven BJM, Åsjö B, Kran AB, Ormaasen V, Aavitsland P, Horban A, Stanczak JJ, Stanczak GP, Firlag-Burkacka E, Wiercinska-Drapalo A, Jablonowska E, Maolepsza E, Leszczyszyn-Pynka M, Szata W, Camacho R, Palma C, Borges F, Paixão T, Duque V, Araújo F, Otelea D, Paraschiv S, Tudor AM, Cernat R, Chiriac C, Dumitrescu F, Prisecariu LJ, Stanojevic M, Jevtovic D, Salemovic D, Stanekova D, Habekova M, Chabadová Z, Drobkova T, Bukovinova P, Shunnar A, Truska P, Poljak M, Lunar M, Babic D, Tomazic J, Vidmar L, Vovko T, Karner P, Garcia F, Paredes R, Monge S, Moreno S, Del Amo J, Asensi V, Sirvent JL, de Mendoza C, Delgado R, Gutiérrez F, Berenguer J, Garcia-Bujalance S, Stella N, de Los Santos I, Blanco JR, Dalmau D, Rivero M, Segura F, Elías MJP, Alvarez M, Chueca N, Rodríguez-Martín C, Vidal C, Palomares JC, Viciana I, Viciana P, Cordoba J, Aguilera A, Domingo P, Galindo MJ, Miralles C, Del Pozo MA, Ribera E, Iribarren JA, Ruiz L, de la Torre J, Vidal F, Clotet B, Albert J, Heidarian A, Aperia-Peipke K, Axelsson M, Mild M, Karlsson A, Sönnerborg A, Thalme A, Navér L, Bratt G, Karlsson A, Blaxhult A, Gisslén M, Svennerholm B, Bergbrant I, Björkman P, Säll C, Mellgren Å, Lindholm A, Kuylenstierna N, Montelius R, Azimi F, Johansson B, Carlsson M, Johansson E, Ljungberg B, Ekvall H, Strand A, Mäkitalo S, Öberg S, Holmblad P, Höfer M, Holmberg H, Josefson P, Ryding U.

Clin Infect Dis. 2016 Mar 1;62(5):655-663. doi: 10.1093/cid/civ963. Epub 2015 Nov 29.

27.

The association between colonization with carbapenemase-producing enterobacteriaceae and overall ICU mortality: an observational cohort study.

Dautzenberg MJ, Wekesa AN, Gniadkowski M, Antoniadou A, Giamarellou H, Petrikkos GL, Skiada A, Brun-Buisson C, Bonten MJ, Derde LP; Mastering hOSpital Antimicrobial Resistance in Europe Work Package 3 Study Team.

Crit Care Med. 2015 Jun;43(6):1170-7. doi: 10.1097/CCM.0000000000001028.

28.

Patterns of drug resistance among newly diagnosed HIV-1 infected patients in Greece during the last decade: the crucial role of transmission networks.

Paraskevis D, Zavitsanou A, Magiorkinis E, Gargalianos P, Xylomenos G, Lazanas M, Chini M, Skoutelis A, Papastamopoulos V, Antoniadou A, Papadopoulos A, Psichogiou M, Daikos G, Vassilakis A, Chrysos G, Paparizos V, Kourkounti S, Sambatakou H, Kordossis T, Koratzanis G, Panagopoulos P, Maltezos E, Drimis S, Hatzakis A.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19742. doi: 10.7448/IAS.17.4.19742. eCollection 2014.

29.

Promoting prudent use of antibiotics: the experience from a multifaceted regional campaign in Greece.

Plachouras D, Antoniadou A, Giannitsioti E, Galani L, Katsarolis I, Kavatha D, Koukos G, Panagopoulos P, Papadopoulos A, Poulakou G, Sakka V, Souli M, Sybardi S, Tsiodras S, Kanellakopoulou K, Giamarellou H.

BMC Public Health. 2014 Aug 22;14:866. doi: 10.1186/1471-2458-14-866.

30.

Prescription of antibiotics and knowledge about antibiotic costs among physicians working in tertiary-care hospitals.

Maltezou HC, Maltezos E, Antoniadou A, Gourgoulis GM, Katerelos P, Adamis G, Petrikkos G, Gargalianos P.

J Chemother. 2014 Dec;26(6):375-8. doi: 10.1179/1973947813Y.0000000160. Epub 2014 Jan 2.

PMID:
24621168
31.

Risk factors for community-associated methicillin-resistant Staphylococcus aureus colonisation in a large metropolitan area in Greece: An epidemiological study using two case definitions.

Tsiodras S, Daikos GL, Lee A, Plachouras D, Antoniadou A, Ploiarchopoulou F, Psichogiou M, Petrikkos G, Harbarth S.

J Glob Antimicrob Resist. 2014 Mar;2(1):27-33. doi: 10.1016/j.jgar.2013.10.001. Epub 2013 Oct 26.

PMID:
27873634
32.

High prevalence of the UGT1A1*28 variant in HIV-infected individuals in Greece.

Panagopoulos P, Paraskevis D, Katsarolis I, Sypsa V, Detsika M, Protopapas K, Antoniadou A, Papadopoulos A, Petrikkos G, Hatzakis A.

Int J STD AIDS. 2014 Oct;25(12):860-5. doi: 10.1177/0956462414523259. Epub 2014 Feb 10.

PMID:
24516079
33.

The impact of an antimicrobial cycling strategy for febrile neutropenia in a haematology unit.

Kontopidou FV, Antoniadou A, Tsirigotis P, Venetis E, Polemis M, Patrinos S, Giamarellou H.

J Chemother. 2013 Oct;25(5):279-85. doi: 10.1179/1973947813Y.0000000077.

PMID:
24070135
34.

Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria.

Antoniadou A, Kanellakopoulou K, Kanellopoulou M, Polemis M, Koratzanis G, Papademetriou E, Poulakou G, Giannitsioti E, Souli M, Vatopoulos A, Giamarellou H.

Scand J Infect Dis. 2013 Jun;45(6):438-45. doi: 10.3109/00365548.2012.760845. Epub 2013 Jan 22.

PMID:
23336730
35.

Effect of HIV type 1 subtype on virological and immunological response to combination antiretroviral therapy: evidence for a more rapid viral suppression for subtype A than subtype B-infected Greek individuals.

Paraskevis D, Touloumi G, Bakoyannis G, Paparizos V, Lazanas M, Gargalianos P, Chryssos G, Antoniadou A, Psichogiou M, Panos G, Katsarou O, Sambatakou H, Kordossis T, Hatzakis A; AMACS.

AIDS Res Hum Retroviruses. 2013 Mar;29(3):461-9. doi: 10.1089/AID.2012.0143. Epub 2012 Nov 6.

PMID:
23034083
36.

Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection.

Papadopoulos AI, Ferwerda B, Antoniadou A, Sakka V, Galani L, Kavatha D, Panagopoulos P, Poulakou G, Protopapas K, van der Meer JW, Netea MG, Giamarellos-Bourboulis EJ.

Cytokine. 2012 Oct;60(1):104-7. doi: 10.1016/j.cyto.2012.05.008. Epub 2012 Jun 8.

PMID:
22683004
37.

Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill.

Mohamed AF, Karaiskos I, Plachouras D, Karvanen M, Pontikis K, Jansson B, Papadomichelakis E, Antoniadou A, Giamarellou H, Armaganidis A, Cars O, Friberg LE.

Antimicrob Agents Chemother. 2012 Aug;56(8):4241-9. doi: 10.1128/AAC.06426-11. Epub 2012 May 21.

38.

Ovarian hyperstimulation syndrome complicated by severe community-acquired pneumonia due to methicillin-resistant Staphylococcus aureus positive for Panton-Valentine leukocidin.

Tsangaris I, Paramythiotou E, Tsaknis G, Argentos S, Antoniadou A, Kopterides P, Armaganidis A.

J Obstet Gynaecol Res. 2012 Feb;38(2):476-8. doi: 10.1111/j.1447-0756.2011.01712.x. Epub 2011 Dec 19.

PMID:
22175531
39.

Variation in genes of β-glucan recognition pathway and susceptibility to opportunistic infections in HIV-positive patients.

Rosentul DC, Plantinga TS, Papadopoulos A, Joosten LA, Antoniadou A, Venselaar H, Kullberg BJ, van der Meer JW, Giamarellos-Bourboulis EJ, Netea MG.

Immunol Invest. 2011;40(7-8):735-50. doi: 10.3109/08820139.2011.599088.

PMID:
21985303
40.

Colonization and infection by colistin-resistant Gram-negative bacteria in a cohort of critically ill patients.

Kontopidou F, Plachouras D, Papadomichelakis E, Koukos G, Galani I, Poulakou G, Dimopoulos G, Antoniadou A, Armaganidis A, Giamarellou H.

Clin Microbiol Infect. 2011 Nov;17(11):E9-E11. doi: 10.1111/j.1469-0691.2011.03649.x. Epub 2011 Sep 21.

41.

HIV-1 outbreak among injecting drug users in Greece, 2011: a preliminary report.

Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Antoniadou A, Lazanas M, Gargalianos P, Psychogiou M, Malliori M, Kremastinou J, Hatzakis A.

Euro Surveill. 2011 Sep 8;16(36). pii: 19962.

42.

Comparison of direct antimicrobial susceptibility testing methods for rapid analysis of bronchial secretion samples in ventilator-associated pneumonia.

Kontopidou F, Galani I, Panagea T, Antoniadou A, Souli M, Paramythiotou E, Koukos G, Karadani I, Armaganidis A, Giamarellou H.

Int J Antimicrob Agents. 2011 Aug;38(2):130-4. doi: 10.1016/j.ijantimicag.2011.04.011. Epub 2011 Jun 12.

PMID:
21658915
43.

Evaluation of CHROMagar™ KPC for the detection of carbapenemase-producing Enterobacteriaceae in rectal surveillance cultures.

Panagea T, Galani I, Souli M, Adamou P, Antoniadou A, Giamarellou H.

Int J Antimicrob Agents. 2011 Feb;37(2):124-8. doi: 10.1016/j.ijantimicag.2010.10.010. Epub 2010 Dec 21.

PMID:
21177079
44.

Two successfully treated cases of Staphylococcus lugdunensis endocarditis.

Chatzigeorgiou KS, Ikonomopoulou C, Kalogeropoulou S, Siafakas N, Giannopoulos G, Antoniadou A, Tassios PT, Tarpatzi E, Giannitsioti E, Vlachakos D, Ikonomopoulos T, Petinaki E, Zerva L.

Diagn Microbiol Infect Dis. 2010 Dec;68(4):445-8. doi: 10.1016/j.diagmicrobio.2010.07.018.

PMID:
21094427
45.

Failure of tigecycline to treat severe Clostridium difficile infection.

Kopterides P, Papageorgiou C, Antoniadou A, Papadomichelakis E, Tsangaris I, Dimopoulou I, Armaganidis A.

Anaesth Intensive Care. 2010 Jul;38(4):755-8.

46.

Microcirculatory vascular dysfunction in HIV-1 infected patients receiving highly active antiretroviral therapy.

Palios J, Ikonomidis I, Lekakis J, Tsiodras S, Poulakou G, Antoniadou A, Panagopoulos P, Papadopoulos A, Giamarellou H, Anastasiou-Nana M, Kremastinos D.

Microcirculation. 2010 May;17(4):303-10. doi: 10.1111/j.1549-8719.2010.00023.x.

PMID:
20536743
47.

Association of toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms with increased infection risk in patients with advanced HIV-1 infection.

Papadopoulos AI, Ferwerda B, Antoniadou A, Sakka V, Galani L, Kavatha D, Panagopoulos P, Poulakou G, Kanellakopoulou K, van der Meer JW, Giamarellos-Bourboulis EJ, Netea MG.

Clin Infect Dis. 2010 Jul 15;51(2):242-7. doi: 10.1086/653607.

PMID:
20521908
48.

Dispensing of antibiotics without prescription in Greece, 2008: another link in the antibiotic resistance chain.

Plachouras D, Kavatha D, Antoniadou A, Giannitsioti E, Poulakou G, Kanellakopoulou K, Giamarellou H.

Euro Surveill. 2010 Feb 18;15(7). pii: 19488.

49.

An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes.

Souli M, Galani I, Antoniadou A, Papadomichelakis E, Poulakou G, Panagea T, Vourli S, Zerva L, Armaganidis A, Kanellakopoulou K, Giamarellou H.

Clin Infect Dis. 2010 Feb 1;50(3):364-73. doi: 10.1086/649865.

PMID:
20041768
50.

Outbreaks of zygomycosis in hospitals.

Antoniadou A.

Clin Microbiol Infect. 2009 Oct;15 Suppl 5:55-9. doi: 10.1111/j.1469-0691.2009.02982.x. Review.

Supplemental Content

Loading ...
Support Center